Manhattan Associates (MANH) Stock Forecast & Price Target

Manhattan Associates is benefiting from a best-in-class platform that customers and partners view as a clear leader in supply chain technology, with strong competitive win rates versus BlueYonder and other category alternatives, while the persistence of legacy on-prem, homegrown, and decades-old systems creates a large replacement opportunity and long-duration customer relationships. Its fundamentals are reinforced by durable growth drivers, including total revenue of $282M up 7% Y/Y, cloud subscription revenue of $117M up 24% Y/Y, total RPO growth of 24%, and adjusted operating income of $91M for a 32.4% non-GAAP operating margin, all of which were supported by strong new logo momentum and broad-based outperformance across cloud, maintenance, and services. The outlook is further strengthened by expanding existing customer usage across the Active Platform, meaningful services upside from customization and integration demand, rising AI monetization potential, and management’s aggressive capital return posture, including about $150M of repurchases in 1Q26 and a larger $500M authorization, signaling confidence in sustained cash generation and long-term growth.

Manhattan Associates is viewed negatively because its reported strength appears to be largely reflected in the updated outlook, with management lifting the revenue midpoint by $9M to $1.152B, raising the Non-GAAP operating margin guide to 35.0%, and increasing the EPS midpoint to $5.33, which suggests upside may already be embedded rather than signaling a new acceleration. The commentary also points to only moderate growth prospects, with the full-year guide implying 7% revenue growth at the midpoint and 11% ex-license and maintenance attrition, while management still expects headwinds from maintenance revenue attrition and only “slightly better than previously modeled” performance in cloud, service, and maintenance revenue. Even though the company benefits from buybacks and prior GTM investments, the outlook remains cautious because the expected execution in 2026 depends on those investments bearing fruit and the stock’s valuation sensitivity to multiple compression leaves limited room for disappointment.